A carregar...
Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis
Although statin treatment leads consistently to a reduction in major adverse coronary events and death in clinical trials, approximately 60 to 70% residual risk of these outcomes still remains. One frontier of investigational drug research is treatment to increase HDL, the ‘good cholesterol’ that is...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3074469/ https://ncbi.nlm.nih.gov/pubmed/20730693 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|